Pharmacology, Diagnosis and Treatments of Psychiatric Diseases
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: 26 August 2025 | Viewed by 83
Special Issue Editors
2. Unit of Psychiatry, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
Interests: mental health; neurobiology neuroscience; women's health; clinical trials; bipolar disorder; mood disorders translation science; research methods
Special Issues, Collections and Topics in MDPI journals
2. Department of Neurosciences, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
Interests: mood; anxiety; psychotic and personality disorders; cardiovascular disorders; clinical psychopharmacology; psychiatric emergencies; pregnancy; femicide; interpersonal violence
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Psychiatric diseases, including disorders such as depression, schizophrenia, bipolar disorder, and anxiety, significantly impact patients’ quality of life and present complex challenges in treatment. Pharmacology plays a vital role in managing these conditions, with medications being tailored to modulate neurotransmitter activity, such as serotonin, dopamine, and norepinephrine, which are central in mood, perception, and cognition. Selective serotonin reuptake inhibitors (SSRIs), antipsychotics, mood stabilizers, and anxiolytics are common pharmacologic interventions used to balance neurotransmitter levels and alleviate symptoms.
The diagnosis of psychiatric disorders is primarily based on clinical assessments and standardized criteria from the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) and ICD-10 (International Classification of Diseases), as there are currently no definitive biomarkers for most conditions. Assessment tools help in evaluating symptom severity and guiding treatment plans.
Treatments are often multifaceted, combining medication with psychotherapy, cognitive behavioral therapy (CBT), and, in some cases, electroconvulsive therapy (ECT) for treatment-resistant cases. Recent advances in pharmacogenomics and neuroimaging hold promise in the development of more personalized treatment approaches, offering hope for improved patient outcomes in psychiatric care through tailored therapies based on individual genetic and neurobiological profiles.
Dr. Giuseppe Marano
Dr. Marianna Mazza
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- mental health disorders
- clinical psychology
- psychopharmacology
- treatment efficacy
- neuroimaging techniques
- personalized medicine
- diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
Planned Papers
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.
